Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study

  1. Verbeek, M.W.C.
  2. Buracchi, C.
  3. Laqua, A.
  4. Nierkens, S.
  5. Sedek, L.
  6. Flores-Montero, J.
  7. Hofmans, M.
  8. Sobral de Costa, E.
  9. Nováková, M.
  10. Mejstrikova, E.
  11. Barrena, S.
  12. Kohlscheen, S.
  13. Szczepanowski, M.
  14. Kulis, J.
  15. Oliveira, E.
  16. Jugooa, R.
  17. de Jong, A.X.
  18. Szczepanski, T.
  19. Philippé, J.
  20. van Dongen, J.J.M.
  21. Orfao, A.
  22. Brüggemann, M.
  23. Gaipa, G.
  24. van der Velden, V.H.J.
Aldizkaria:
British Journal of Haematology

ISSN: 1365-2141,  0007-1048

Argitalpen urtea: 2022

Alea: 197

Zenbakia: 1

Orrialdeak: 76-81

Mota: Artikulua

DOI: 10.1111/BJH.17992 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus